Smruthi Organics (BOM:540686) Debt-to-Equity : 0.17 (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Smruthi Organics Debt-to-Equity?

Smruthi Organics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹61 Mil. Smruthi Organics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹56 Mil. Smruthi Organics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹696 Mil. Smruthi Organics's debt to equity for the quarter that ended in Mar. 2024 was 0.17.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Smruthi Organics's Debt-to-Equity or its related term are showing as below:

BOM:540686' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.57 Max: 1.57
Current: 0.17

During the past 13 years, the highest Debt-to-Equity Ratio of Smruthi Organics was 1.57. The lowest was 0.04. And the median was 0.57.

BOM:540686's Debt-to-Equity is ranked better than
62.25% of 845 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs BOM:540686: 0.17

Smruthi Organics Debt-to-Equity Historical Data

The historical data trend for Smruthi Organics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smruthi Organics Debt-to-Equity Chart

Smruthi Organics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.37

0.17

0.04

0.08

0.17

Smruthi Organics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.08	N/A	0.14	N/A	0.17

Competitive Comparison of Smruthi Organics's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Smruthi Organics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smruthi Organics's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Smruthi Organics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Smruthi Organics's Debt-to-Equity falls into.

Smruthi Organics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Smruthi Organics's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(61.417	+	55.617)	/	696.187
	=	0.17

Smruthi Organics's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(61.417	+	55.617)	/	696.187
	=	0.17

Smruthi Organics (BOM:540686) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Smruthi Organics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Smruthi Organics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Smruthi Organics (BOM:540686) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Smruthi Organics Ltd (BOM:540686) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

165-A, Balaji Bhavan, 1st Floor, Railway Lines, Solapur, MH, IND, 413 001

Website

https://www.smruthiorganics.com

Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium and many more. It has two segments Bulk Drugs and Drugs Intermediates (API) and Formulation. it generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment.

Smruthi Organics (BOM:540686) Headlines

No Headlines